Ignite Creation Date:
2024-05-05 @ 4:49 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00327262
Status:
UNKNOWN
Last Update Posted:
2006-06-20
First Post:
2006-05-16
Brief Title:
Comparing Imatinib Standard Dose With Imatinib High Dose Induction in Pretreated Chronic Myeloid Leukemia CML Patients in Chronic Phase
Sponsor:
Central European Leukemia Study Group
Organization:
Central European Leukemia Study Group
Organization Data
Organization:
Central European Leukemia Study Group
Class:
OTHER
Study ID:
CSTI571AAT06
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Central European Leukemia Study Group
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None